ST101: Preclinical & Phase 1 Results Targeting C/EBPβ

Time: 2:30 pm
day: Day Two

Details:

• Discuss the key goals that were set out entering phase 1 and the rationale behind them
• Explain how the preclinical insights led the decision making efforts as Sapience entered phase 1

Speakers: